Abstract:Antimicrobial peptides (AMPs) are naturally produced by pro- and eukaryotes and are promising alternatives to antibiotics to fight multidrug-resistant microorganisms. However, despite thousands of AMP entries in respective databases, predictions about their structure–activity relationships are still limited. Similarly, common or dissimilar properties of AMPs that have evolved in different taxonomic groups are nearly unknown. We leveraged data entries for 10,987 peptides currently listed in the three antimicrobial peptide databases APD, DRAMP and DBAASP to aid structure–activity predictions. However, this number reduced to 3,828 AMPs that we could use for computational analyses, due to our stringent quality control criteria. The analysis uncovered a strong bias towards AMPs isolated from amphibians (1,391), whereas only 35 AMPs originate from fungi (0.9%), hindering evolutionary analyses on the origin and phylogenetic relationship of AMPs. The majority (62%) of the 3,828 AMPs consists of less than 40 amino acids but with a molecular weight higher than 2.5 kDa, has a net positive charge and shares a hydrophobic character. They are enriched in glycine, lysine and cysteine but are depleted in glutamate, aspartate and methionine when compared with a peptide set of the same size randomly selected from the UniProt database. The AMPs that deviate from this pattern (38%) can be found in different taxonomic groups, in particular in Gram-negative bacteria. Remarkably, the γ-core motif claimed so far as a unifying structural signature in cysteine-stabilised AMPs is absent in nearly 90% of the peptides, questioning its relevance as a prerequisite for antimicrobial activity. The disclosure of AMPs pattern and their variation in producing organism groups extends our knowledge of the structural diversity of AMPs and will assist future peptide screens in unexplored microorganisms. Structural design of peptide antibiotic drugs will benefit using natural AMPs as lead compounds. However, a reliable and statistically balanced database is missing which leads to a large knowledge gap in the AMP field. Thus, thorough evaluation of the available data, mitigation of biases and standardised experimental setups need to be implemented to leverage the full potential of AMPs for drug development programmes in the clinics and agriculture.

The evolution of the antimicrobial peptide database over 18 years: Milestones and new features

The antimicrobial peptide database is 20 years old: Recent developments and future directions

APD3: the antimicrobial peptide database as a tool for research and education

Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides

The antimicrobial peptide database provides a platform for decoding the design principles of naturally occurring antimicrobial peptides

dbAMP 2.0: updated resource for antimicrobial peptides with an enhanced scanning method for genomic and proteomic data

dbAMP 3.0: updated resource of antimicrobial activity and structural annotation of peptides in the post-pandemic era

Database Resources Dedicated to Antimicrobial Peptides

DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides

Developments with investigating descriptors for antimicrobial AApeptides and their derivatives

LAMP2: a major update of the database linking antimicrobial peptides

Antimicrobial Peptides: An Update on Classifications and Databases

Computational resources and tools for antimicrobial peptides

Computational Methods and Tools in Antimicrobial Peptide Research

Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded

Mining the UniProtKB/Swiss-Prot database for antimicrobial peptides

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

ESKtides: a comprehensive database and mining method for ESKAPE phage-derived antimicrobial peptides

Realistic and critical review of the state of systemic antimicrobial peptides

Structure–Activity Predictions From Computational Mining of Protein Databases to Assist Modular Design of Antimicrobial Peptides

Overlap and diversity in antimicrobial peptide databases: compiling a non-redundant set of sequences